Critical Insights From Apellis Pharmaceuticals Analyst Ratings: What You Need To Know
Critical Insights From Apellis Pharmaceuticals Analyst Ratings: What You Need To Know
來自apellis pharmaceuticals分析師評級的重要見解：你需要了解的事情
The analysis of recent analyst actions sheds light on...During the last three months, 13 analysts shared their evaluations of Apellis Pharmaceuticals (NASDAQ:APLS), revealing diverse outlooks from bullish to bearish.
在過去的三個月中，13位分析師分享了對Apellis Pharmaceuticals（納斯達克：apellis pharmaceuticals）的評價，展現了從看好到看淡的不同前景。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估，下表展示了過去30天內不斷變化的情緒，並將其與之前的幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $79.69, along with a high estimate of $100.00 and a low estimate of $46.00. Observing a downward trend, the current average is 7.24% lower than the prior average price target of $85.91.
爲提供更深入的見解，分析師建立了12個月的價格目標，均值爲79.69美元，高估爲100.00美元，低估爲46.00美元。觀察到下降趨勢，目前的均值比之前的平均價格目標85.91美元低7.24％。
Exploring Analyst Ratings: An In-Depth Overview
分析師評級:深入了解
The analysis of recent analyst actions sheds light on...
對近期分析師行動的...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。